GRO Biosciences Funding: $91M Raised, Series B (2024)
GRO Biosciences is a Biotech company based in Cambridge, Massachusetts. It has raised $91M in total funding. Latest round: Series B.
GRO Biosciences funding overview
GRO Biosciences is a Biotech company based in Cambridge, Massachusetts. GRO Biosciences has raised $91M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2024. The round record for GRO Biosciences runs through 2024; nothing later has been disclosed. Investors on record include Atlas Venture, Access Biotechnology, Leaps by Bayer, Redmile Group, Digitalis Ventures, Innovation Endeavors and 3 others. 9 distinct backers are named across the disclosed rounds.
GRO Biosciences has raised $91M in total disclosed funding across the rounds on record.
Who has invested in GRO Biosciences?
Atlas Venture, Access Biotechnology, Leaps by Bayer, Redmile Group, Digitalis Ventures, Innovation Endeavors are named among the investors backing GRO Biosciences.
What was the latest GRO Biosciences funding round?
The most recent disclosed round is a Series B, announced in July 2024.
Where is GRO Biosciences based?
GRO Biosciences is based in Cambridge, Massachusetts.
What sector does GRO Biosciences operate in?
GRO Biosciences is tracked under Biotech from Cambridge, Massachusetts, with $91M in disclosed funding.
When did GRO Biosciences last raise?
The last disclosed GRO Biosciences round closed in July 2024 at Series B.
Totals shown for GRO Biosciences aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Cambridge and the investors behind them below.
